Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 13, 2024
Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
Maryam Zafer, Shravan Dave
Alimentary Pharmacology & Therapeutics
|
October 14, 2024
Editorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE?
Kelly Torosian, Shravan Dave
Alimentary Pharmacology & Therapeutics
|
July 31, 2021
Editorial: trends in alcohol use and alcohol-related liver disease in the US population
Abbey Barnard, Shravan Dave
Clinical Liver Disease
|
February 8, 2021
CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient
Shravan Dave, Abbey Barnard, Michel Mendler
Clinical Liver Disease
|
December 25, 2023
Nephrology for the transplant hepatologist
Zachary Gitto, Pranab Barman, Shravan Dave
Gastroenterology
|
February 17, 2020
Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease
Anand R Saran, Shravan Dave, Amir Zarrinpar
Infection and Drug Resistance
|
March 13, 2026
Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies
Renato Bobadilla, Finn MacLean, Shravan Dave, et al.
JAMA
|
April 3, 2014
Academic medical center leadership on pharmaceutical company boards of directors
Timothy S Anderson, Shravan Dave, Chester B Good, et al.
Infection and Drug Resistance
|
May 20, 2026
The HIV/HBV Co‑infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter]
Renato Bobadilla, Finn MacLean, Shravan Dave, et al.
Hepatology (Baltimore, Md.)
|
April 12, 2020
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Shravan Dave, Sooyoung Park, M Hassan Murad, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Alimentary Pharmacology & Therapeutics
|
August 13, 2024
Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
Maryam Zafer, Shravan Dave
Alimentary Pharmacology & Therapeutics
|
October 14, 2024
Editorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE?
Kelly Torosian, Shravan Dave
Alimentary Pharmacology & Therapeutics
|
July 31, 2021
Editorial: trends in alcohol use and alcohol-related liver disease in the US population
Abbey Barnard, Shravan Dave
Clinical Liver Disease
|
February 8, 2021
CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient
Shravan Dave, Abbey Barnard, Michel Mendler
Clinical Liver Disease
|
December 25, 2023
Nephrology for the transplant hepatologist
Zachary Gitto, Pranab Barman, Shravan Dave
Gastroenterology
|
February 17, 2020
Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease
Anand R Saran, Shravan Dave, Amir Zarrinpar
Infection and Drug Resistance
|
March 13, 2026
Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies
Renato Bobadilla, Finn MacLean, Shravan Dave, et al.
JAMA
|
April 3, 2014
Academic medical center leadership on pharmaceutical company boards of directors
Timothy S Anderson, Shravan Dave, Chester B Good, et al.
Infection and Drug Resistance
|
May 20, 2026
The HIV/HBV Co‑infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter]
Renato Bobadilla, Finn MacLean, Shravan Dave, et al.
Hepatology (Baltimore, Md.)
|
April 12, 2020
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Shravan Dave, Sooyoung Park, M Hassan Murad, et al.
Page
of 2